MedTrace Logo

Diabetic Neuropathy Topical Treatment

NCT00661063 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2008-04-18

No results posted yet for this study

Summary

Comparative study of efficacy and safety of ketamine, clonidine, mixture of both and placebo in patients with diabetic neuropathic pain

Conditions

  • Diabetic Neuropathy
  • Pain

Interventions

DRUG

ketamine

ketamine 150 mcg/g bid

DRUG

vehicle gel

bid - 12 weeks

DRUG

ketamine + clonidine

ketamine 150mcg/g + clonidine 1% gel bid 12 weeks

DRUG

clonidine gel 1%

bid 12 weeks

Sponsors & Collaborators

  • Irmandade da Santa Casa de Misericordia de Sao Paulo

    lead OTHER

Principal Investigators

  • Judymara L Gozzani, Investigator · Santa Casa de São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-04-30
Completion
2009-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00661063 on ClinicalTrials.gov